Exodus Point Capital Management, LP Neoleukin Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 19, 2022	SELL	$0.92 - $2.25 $14,235 - $34,814	-15,473 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.72 - $5.23 $26,613 - $80,923	15,473 New	15,473 $29,000
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.75 $52,986 - $88,311	-11,395 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.05 - $9.66 $39,089 - $62,413	-6,461 Reduced 36.18%	11,395 $82,000
Q2 2021 Aug 16, 2021	BUY	$9.23 - $13.12 $164,810 - $234,270	17,856 New	17,856 $165,000

Q2 2020 Aug 14, 2020	SELL	$9.95 - $17.05 $827,352 - $1.42 Million	-83,151 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.12 - $13.64 $257,456 - $573,807	-42,068 Reduced 33.6%	83,151 $946,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $12.72 $331,830 - $1.59 Million	125,219 New	125,219 $1.54 Million

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.